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The MDM2 protein is an ubiquitin ligase that plays a critical role in
regulating the levels and activity of the p53 protein, which is a central
tumor suppressor. A SNP in the human MDM2 gene (SNP309 T/G)
occurs at frequencies dependent on demographic history and has
been shown to have important differential effects on the activity of
the MDM2 and p53 proteins and to associate with altered risk for the
development of several cancers. In this report, the haplotype struc-
ture of the MDM2 gene is determined by using 14 different SNPs
across the gene from three different population samples: Caucasians,
African Americans, and the Ashkenazi Jewish ethnic group. The
results presented in this report indicate that there is a substantially
reduced variability of the deleterious SNP309 G allele haplotype in all
three populations studied, whereas multiple common T allele haplo-
types were found in all three populations. This observation, coupled
with the relatively high frequency of the G allele haplotype in both
and Caucasian and Ashkenazi Jewish population data sets, suggests
that this haplotype could have undergone a recent positive selection
sweep. An entropy-based selection test is presented that explicitly
takes into account the correlations between different SNPs, and the
analysis of MDM2 reveals a significant departure from the standard
assumptions of selective neutrality.
cancer  p53  population genetics  SNP  entropy
In response to a wide variety of stresses, such as DNA damage oroncogene activation, the p53 tumor suppressor protein is acti-
vated and initiates a transcriptional program leading to cell cycle
arrest, cell senescence or apoptosis (1). This eliminates clones of
cells that have acquired mutations, which arise at a high frequency
whenDNAreplication or the cell cycle proceeds under stress.When
the p53 gene is mutated in either the germ line or in a somatic cell,
many types of cancers can arise (2). The p53 protein is regulated by
a ubiquitin ligase, the MDM2 protein, which binds to p53, blocking
its function as a transcription factor, and polyubiquitinates the p53
protein sending it to the proteiosome for degradation (3). The
MDM2 gene in turn is positively regulated by p53-mediated tran-
scription, setting up an autoregulatory loop that keeps both proteins
at moderate levels. Stress responses perturb this feedback loop,
which leads to the initiation of p53-dependent apoptosis.
Functional SNPs in the human genome have been identified in
both the p53 and the MDM2 genes (4). In the p53 gene, a SNP
(codon 72) results in the change of a proline residue to an arginine
at codon 72 of the p53 protein (p53-Pro and p53-Arg, respectively).
Multiple groups have shown that p53-Pro is weaker than p53-Arg
in its ability to both suppress cellular transformation and induce
apoptosis in cell culture (5–8), and can associate with an earlier
onset of tumor formation and a poorer tumor response to chemo-
therapy in humans (7, 9, 10). In the MDM2 gene, a SNP (SNP309)
results in a nucleotide change from the wild-type thymine (T) to
guanine (G) in the intronic promoter/enhancer region (11). The G
allele increases the binding of a transcription factor, SP1, which in
turn results in higher levels of MDM2 RNA and protein, the
attenuation of the p53 pathway and an enhanced early onset of, and
increased risk for, tumorigenesis (11–22). More recent studies of
MDM2 SNP309 suggest that primarily female specific hormones,
like estrogen, either directly or indirectly, allow for the G allele of
SNP309 to accelerate tumor formation in women in four different
sporadic cancers (diffuse large B cell lymphoma, soft tissue sar-
coma, invasive ductal breast carcinoma and colorectal cancer) (14,
23). Together, these data suggest that functional SNPs in the p53
pathway will play a role in regulating the efficiency of the p53 stress
response over a lifetime, and as such the efficacy of the p53 pathway
in tumor suppression after exposure to stresses.
To date all of the associations of the G allele of MDM2 SNP309
with the early onset of cancers in patients have been linked to this
locus alone and little is known of the haplotypes that contain the G
or the T alleles at SNP309. It remains possible that one or several
G haplotypes will be associated with early onset of cancer, and it is
important to determine this at an early stage in the genetic
epidemiological studies of this allele. For that reason, the haplotype
structure of 14 different SNPs in theMDM-2 gene was determined
by employing three different racial and ethnic populations: one
African American population, one Caucasian not selected for
ethnicity, and one Caucasian of theAshkenazi Jewish ethnic group.
These populations were chosen for further haplotype analysis, as it
had been previously observed that African Americans have a low
Gallele frequency, non-JewishCaucasians an intermediateG allele
frequency, and Ashkenazi Jewish groups a high G allele frequency
(14, 24).
The results presented in this report indicate that there are only
a few common (1%) G allele haplotypes in all three populations
studied, one in the African American and Caucasian data sets and
two in the Ashkenazi Jewish data set. The SNPs in the G allele
haplotype are thus highly correlated. We suggest that the single G
allele haplotype in the African American population could have
arisen through admixture with other racial groups, like Caucasians,
and thus is a relatively recent mutation. In contrast, multiple
common T allele haplotypes were found in all three populations,
thus exhibiting reduced correlations between the SNPs. This ob-
servation coupled with the relatively high frequency of the G allele
haplotype in both Caucasian populations suggests that this haplo-
type could have experienced recent positive selection pressure. To
test this hypothesis, an entropy-based selection test is devised that
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compares both the frequency and long-range correlations of the
allele with a simulated model where the allele is selectively neutral.
The results confirm that the probability that the G allele haplotype
is selectively neutral is quite low.
Results
TheMDM2 SNPs genotyped from various populations in this study
are depicted in Fig. 1, and their frequencies are detailed in Tables
1 and 2. The observed genotype frequencies of the MDM2 SNPs
were found not to deviate significantly from Hardy–Weinberg
equilibrium within each race and ethnic group, with P values
ranging from 0.08 to 1.00. As expected, the assumption of Hardy–
Weinberg equilibrium was found to be notably violated when the
populations were pooled together. The frequencies of the SNPs
common to both studies are, on average, most similar between the
Caucasian and Ashkenazi Jewish data sets. However, because the
absolute frequencies of the common SNPs across the Caucasian
andAshkenazi Jewish samples do notmatch exactly, there is no way
of combining the haplotypes without incurring severe biases.
All haplotypes with an expected frequency of at least 1% are
presented in Figs. 2, 3, and 4 for Caucasians, African Americans,
and Ashkenazi Jewish data sets, respectively. The marginal haplo-
type frequencies inferred from this calculation are shown in the
figures in a SNP309-centric fashion, adding additional SNPs about
SNP309 two at a time so as to permit comparisons of subhaplotypes.
Previously reported SNP309 G allele frequencies in Northern
European Caucasians were 33%, but in African Americans they
have been noted to be significantly lower, 11% (14, 24, 25). A
salient feature of the African Americans and Caucasians figures is
that, in both populations, theGallele of SNP309 is highly correlated
with all of the other SNPs across the entire region of MDM2
covered by the Celera Diagnostic SNP set, resulting in only one G
haplotype in both populations. The G allele haplotype is identical
in both races, just at a much lower frequency in African Americans
(43% vs. 10%), possibly suggesting that its presence in African
Americans could be due to an admixture (25). If true, this would
lead to the prediction that Africans probably do not carry the G
allele of SNP309, which then posits the idea that the G allele could
have arisen more recently in evolution.
Evidence of recombination was determined by the four-gamete
test, serving as a guide to the minimum number of recombination
events consistent with the data. Of the possible 55 pairs, there were
seven positive tests in both the African American and Caucasians
populations, and five out of 15 in the Jewish ethnic population. To
directly ascertain the correlations among SNPs of the MDM2 gene
in the differing population data sets, the linkage disequilibrium of
the MDM2 SNPs was estimated by calculating the standard pair-
wise values of D and r2 (Fig. 5). The linkage disequilibrium
estimation analysis of the MDM2 SNPs revealed that the SNP309
locus is absolutely correlated with two other MDM2 SNPs, Cel5
and Cel8. These three SNPs seem to always travel together in a
haplotype, and thus collectively they represent only one degree of
freedom in genetic variation. Hence, there is no detectable simple
single mutation precursor of the G allele haplotype of SNP309
amongst the T allele haplotypes in both populations.
Table 2. Major allele frequencies of the six SNPs genotyped in
the Sheba study
SNP ID
dbSNP
ID
Major/minor
allele
Ashkenazi Jewish
frequency
She1 rs2088578 G/A 0.66
She2 rs1144943 T/G 0.73
She3 rs937283 A/G 0.74
She4 rs2279744 G/T 0.54
She5 rs2291857 C/A 0.63
She6 rs3730581 A/G 0.57
Fig. 1. Schematic diagram of the MDM2 gene and
the SNPs genotyped in the present study. The three
SNPs common to both the Celera and Sheba data sets
are indicated by the dotted lines.
Table 1. Major allele frequencies of the 11 SNPs genotyped in
the Celera study
Frequency
SNP ID
dbSNP
ID
Major/minor
allele
African
American Caucasian
Cel1 rs937283 A/G 0.74 0.66
Cel2 rs2870820 C/T 0.94 0.66
Cel3 rs2279744 T/G 0.90 0.57
Cel4 rs1196335 T/A 0.77 0.66
Cel5 rs3730536 A/G 0.90 0.57
Cel6 rs1625525 T/C 0.78 0.66
Cel7 rs1201644 A/G 0.73 0.63
Cel8 rs3730581 G/A 0.90 0.57
Cel9 rs3730597 C/G 1.00 0.99
Cel10 rs3730635 A/G 0.82 0.97
Cel11 rs1695147 T/G 0.41 0.80
The labeling of major and minor allele was determined by pooling both the
African American and Caucasian population samples.
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Independent evolution of subpopulations results in reduced
heterozygosity of the total population as detected by Wright’s F
statistic. For the Caucasian and African American populations, we
find that FST  0.17, mirroring the observation from the allelic
Hardy–Weinberg tests that mating was essentially random within
each race but not between the races. The data across the races was
permuted 110 times and the calculated FST statistic indicated that
P 105 (26). The average number of pairwise distances between
the two races was   4.3 with P  105.
Although the G allele occurs at intermediate frequencies, it is a
striking observation that the number of different G allele haplo-
types across the entire gene is dramatically reduced compared with
the number of T allele haplotypes even though the T allele
frequency is also intermediate in the non-African-American pop-
ulations. How significant then is the paucity of the G allele
haplotypes and what biological implications, if any, does it suggest?
To quantify the total variation of haplotypes within each popu-
lation for an arbitrary number of SNPs, we appealed to information
theory (27) and estimated the entropy, which serves as a unique
measure of variability under a few, but very general, mathematical
assumptions. To be more specific, we calculated the multientropy
H[{X}] from the observed haplotypes arising from a set, {X}, of b
SNPs, H[{X}]  i1
2b pi(x1x2. . . xb)log2 pi(x1x2. . . xb), where each
random variable xi denotes one of the two alleles of SNP i.
Concavity of the entropy function results, on average, in a negative
sampling bias, which can be corrected by using a bootstrap resam-
pling procedure to extrapolate to the infinite sample size (28).
Under the standard simple assumptions of a large panmictic
population the variability of a stretch of the genome increases with
time or, more accurately, number of generations, because of
increased probability of recombination and mutation. The total
entropy of the African American and Caucasian haplotypes in the
Celera data set was calculated to be 3.0 bits and 2.05 bits, respec-
tively, supporting the idea that the Caucasians are a much more
recent interbreeding population than the Africans.
A large level of linkage disequilibrium across the gene entails a
low level of multientropy. It is expected from simple considerations
of a neutral model of a population of mutating and recombining
chromosomes that low frequency (younger) alleles ought to occur
on fewer haplotypes than higher frequency (older) alleles, and thus
will be in strong linkage disequilibrium across relatively large
stretches of the genome. To capture this intuition, we suggest that,
under the assumptions of a neutral model, there ought to be a
monotonically increasing relationship between the frequency of the
allele and the mean entropy of the associated haplotypes. To show
this, we generated samples of polymorphic data from a Monte
Carlo simulation within a coalescent framework of neutral muta-
tion and homogeneous recombination (29). In Fig. 6a, we show a
plot of the entropy of haplotypes around a particular SNP with
distance (base pairs) away from the SNP. For low-frequency alleles,
the entropy of associated haplotypes rises slowly with distance away
from the allele because low-frequency alleles are usually recently
occurring mutations that have not had sufficient time to attain
linkage equilibrium with surrounding SNPs. Higher frequency
alleles, as expected, exhibit a much greater increase in linkage
equilibrium and entropy. Tomake comparisons between the alleles
of a particular SNP, we summarize the linkage equilibrium for each
allele by calculating the distance-averaged entropy up to some
cutoff distance away from the SNP. The cutoff in our study here has
a natural upper bound due to the limited number of SNPs geno-
typed across the genetic region of interest.More generally, a natural
cutoff is given by the accuracy by which we can calculate the
entropy, and a simple large-sample calculation of the first-order
error in entropy estimation shows that the criteria for accurate
entropy estimation is a function of N, the number of samples, and
b, the number of SNPs, (i.e., 2bN1 1). Decreasing the cutoff
arbitrarily results in greater variability of the distribution of linkage
equilibrium for a given allele and, conversely, increasing the cutoff
compromises the accuracy of entropy, and thus there ought to be
an optimal intermediate cutoff where both effects are mitigated.
By comparing the differences of average linkage equilibrium for
different alleles at a particular SNP, we are able to obviate the
systematic error that occurs due to variable recombination rates
across the genome. Thus, the summary statistic of the differential
mean linkage equilibrium (DLE) for an allele A is given by
DLE
1
2z0,cHcA HcB	zc1,c i1
c1
Hi
A Hi
B	zi1,i
1 ,
[1]
Fig. 2. Inferred haplotype frequencies in the Caucasian population.
Fig. 3. Inferred haplotype frequencies in the African American population.
Fig. 4. Inferred haplotype frequencies in the Ashkenazi Jewish population.
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where the index B refers to the other allele at the locus, c is the
number of SNPs before the cutoff, zi,j is the base pair distance
between SNPs situated at loci i and j, and Hi
A,B is the multientropy
for i SNPs extending away from a particular locus, conditional on
either allele A or B at locus i 0. In Fig. 6b, we summarize the data
of allele frequency and DLE showing the expected relationship
under the neutral model, whereby high-frequency alleles have
positive DLE and low-frequency alleles have negative DLE. Any
deviation from this would be due to a relaxation of the standard
assumptions of a neutralmodel.An allelewith a large frequency but
low DLE is suggestive of a selection pressure that has rapidly
pushed up the frequency of the allele giving it insufficient time to
approach equilibration with surrounding SNPs. As proof of prin-
ciple, we then generated aMonteCarlo sample of polymorphic data
where one allele was preassigned to have a weak positive selection
pressure (selective advantage per copy per generation  0.1) (30).
The summary plot of the DLE values for all SNPs (Fig. 6c) shows
that the selected allele does indeed significantly deviate from the
mean of the null distribution. Indeed, recent work (31, 32) has
provided supportive evidence that such haplotype-based methods
are far more sensitive to recent selection detection. The P value was
estimated by Monte Carlo simulation of a neutral model (31) with
106 trials to provide a fine-scale distribution of neutral DLE for a
given allele frequency where the frequencies were quantized into
steps of 0.1.
Previous tests of selection in the population genetics literature
also look for deviations away from the neutrality but do not
incorporate information from multiallelic associations even
though selection pressure can have a strong effect on levels of
linkage disequilibrium, and thus these tests have low power to
detect recent selective sweeps (32). Nevertheless, we used a
variety of standard selection tests on the population data sets,
and the results, as detailed in Table 3, are inconsistent with
rejecting the null hypothesis of a neutral model, with each
population data set showing significant departure or not from
neutrality depending on which selection test is used. Our pro-
posed test of neutrality does not rest on an assumption
of independent alleles but is explicitly based on the variability of
haplotypes and hence also linkage disequilibrium.
Fig. 5. Pairwise linkage disequilibrium for Ashkenazi Jewish (a), Caucasian
(b), and African American (c) populations. The upper right triangle reports the
D measure, and the lower left triangle reports the r2 measure. SNP309 is
highlighted in all populations.
Fig. 6. Monte Carlo simulation of haplotypes. (a) The conditional multien-
tropy of the adjacent SNPs is plotted for a particular locus where the minor
allele (lower curve) had a frequency of 0.19 and the major allele (upper curve)
had a frequency of 0.81. The unit of distance is measured in rescaled base pairs.
(b) Plot of the DLE values versus frequency of each allele. One thousand Monte
Carlo genome samples of size 250,000 base pairs were generated. The muta-
tion rate was set to produce 8,000 SNPs, and the recombination rate was set
to 1 cM Mb1. (c) Selected allele (indicated by arrow) underwent a selective
advantage per copy per generation of 0.1
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When we calculated the frequency versus DLE relationship for
theMDM2 SNPs, we found that the G allele of SNP309, along with
theminor alleles of SNPsCel5 andCel8, did indeed showevidence
of significant deviation away from the frequency versus DLE
relationship determined by the other alleles in the study. To assess
significance, we ran neutral simulations with matching number of
SNPs, constructed with the inferred average recombination rate
parameter of 0.43 cm/Mb1 (from PHASE v2.1) across theMDM2
gene, and found that the (Bonferroni-corrected) P value was0.01
for the Caucasians not selected for ethnicity and 0.03 for the
Ashkenazi Jewish Caucasians. Another haplotype-based method
designed to detect recent selection (31) was used and found that the
deviation from neutral simulation results were also significant in
both Caucasian populations with P  0.04. The data suggest that
only the G allele haplotype has been pushed up in frequency
because of a recent positive selection pressure.
Discussion
It had been shown that MDM2 SNP309 occurs at race- and
ethnicity-specific frequencies (14, 24). In this report, these obser-
vations were extended to the haplotype structure of this important
oncogene. Specifically, in the Caucasian population not selected for
ethnicity and in the African American population, only one major
haplotype for the G allele of MDM2 SNP309 was observed (Figs.
2 and 3). This observation, plus the low frequency of the G allele
haplotype in African Americans (43% in Caucasians vs. 10% in
African Americans), supports the idea that the G haplotype could
have arisen in this racial group from admixture with Caucasians.
This finding allows for the possibility that the T to G change could
have occurred more recently in human evolution, namely after the
initial migrations of humans out of Africa. It is intriguing to
speculate whether the two common G haplotypes in the Ashkenazi
Jewish data set are unique to this ethnic Caucasian group, but is
impossible to know as the analysis of the twoCaucasian populations
differed in the MDM2 SNPs genotyped.
Interestingly, one common trait of all three populations in this
study was the large number of common (3%) SNP309 T allele
haplotypes compared with the small number ofG allele haplotypes.
Specifically, anywhere from two common T allele haplotypes were
found in the Caucasian population not selected for ethnicity (Fig.
2), to eight in African Americans (Fig. 3), to four in the Ashkenazi
Jewish population (Fig. 4). This observation, coupled with the
relatively high frequency of the G allele haplotype in the Caucasian
populations, suggests that this haplotype could have experienced
positive selection pressure. This hypothesis was tested by developing
a statistical model of the predicted entropy of haplotypes under the
assumption of neutral polymorphisms (Fig. 6). Indeed, the results
demonstrate that the G allele haplotype deviates significantly from
the neutralmodel in both theCaucasian population data set and the
Ashkenazi Jewish population data set (P  0.01 and P  0.03,
respectively). Similar results were obtained by using previously
published haplotype-based method of detecting selection (31).
Together, these data support the hypothesis that the G haplotype
may have undergone a recent selective sweep.
Another effect that would also result in the loss of haplotype
variability while pushing up the G allele frequency is a founder
effect in which the SNP309 T to G mutation occurred late in the
parent population. However, this would affect the DLE of all of the
SNPs in the founding population, not just SNP309,which is notwhat
we observe.On a relatedmatter, we also point out that the selection
arguments drawn here, because of the limited number of SNPs in
the study, are contingent on rejecting a specified null hypothesis,
constructed from simulating the standard neutral model. Future
workmay provide genotypes of amuch larger region of the genome
around MDM2, which would allow us to compare the relative
selective pressure of SNP309 with the rest of the genome,
assumed to be mostly neutral, and not just with a simulated neutral
model (32).
Curiously, there seems to be no observable simple one step
mutation to derive the G haplotypes from any of the T allele
containing haplotypes. Rather, the G allele is in high linkage
disequilibrium with two other MDM2 SNPs (Cel-5 and Cel-8, Fig.
5), suggesting that these three SNPs arose in a narrow window of
time on a common haplotype background.
An interesting model for positive selection of the functional SNP
in the p53 gene, codon 72, has been previously proposed to explain
the observation that the p53–Pro isoform increases in a monotonic
manner inmultiple populations as they near the equator (in Africa)
(33). As mentioned earlier, the p53–Pro isoform is weaker than
p53–Arg in its ability to both suppress cellular transformation and
induce apoptosis in cell culture (5–8), and can associate with an
earlier onset of tumor formation and a poorer tumor response to
chemotherapy in humans (7, 9, 10). The data presented in this and
previous reports suggest that Africans will have a very low fre-
quency, if not zero, of the G allele of SNP309, whereas Caucasians
and Asians will a much higher G allele frequency (14, 16, 21, 22, 24,
33). Because the G allele of SNP309 has a lower apoptotic fre-
quency than the T allele in some cell types in culture (11, 13), it is
tempting to speculate that the presence of the G allele could
compensate for higher apoptotic frequencies brought about by the
p53–Arg isoform as populations move to northern Asia and Eu-
rope. A well regulated p53 pathway has been shown in many
organisms to be crucial not only for tumor suppression but also for
proper embryonic development (34, 35); therefore, selection pres-
sure on the p53 pathway could be possible. In fact, the p53 pathway
also responds to inflammation, raising the possibility that infectious
diseases could play a role in the selection of p53 pathway SNPs, like
MDM2 SNP309 and codon 72.
Materials and Methods
Sample Populations. Two separate genotyping assays were carried
out for theMDM2 gene, one performed byCeleraDiagnostics, and
the other performed by the Sheba Cancer Research Center. These
two studies assayed a different set of SNPs in the differing popu-
lations. A combined total of 14 different SNPs were typed across a
region spanning32,000 bp, including a region 4,000 bp upstream
from the first exon (see Fig. 1 and Tables 1 and 2). Both studies
included SNP309 (identified as Cel3 and She4 in the two data
sets).
Celera Diagnostics. Sample population. Eleven SNPs were genotyped
from a collection of 113 lymphoblastoid cell lines from Caucasian
and African American individuals obtained from the Coriell Di-
versity Set of cell lines that had been previously analyzed for their
frequencies of apoptosis and their associated SNPs (24). Subse-
quent to the publication of those results it was determined, and it
was confirmed by the Coriell Institute, that 22 of the cell lines used
(eachwith a different number) in that studywere duplicates derived
from the same individuals even though this is not indicated in their
information. These duplicate cell lines are presented in supporting
information (SI) Tables 4 and 5. It was also determined that 32 of
the SNP309 MDM2 genotypic assignments made in Harris et al.
were incorrect. These genotypes are now corrected and presented
in SI Table 6. Because of these changes in the data set, the MDM2
SNP309 is not very significantly associated with a low apoptotic
frequency in these cell lines (P  0.15) as had been reported (24).
This is probably due to the observation that an active estrogen-
Table 3. Results of various selection tests
Population data set Fu and Li’s F Fu and Li’s D Tajima’s D
Caucasian 1.59 (0.05) 0.80 (0.10) 2.35 (0.05)
African American 1.62 (0.05) 1.36 (0.10) 1.37 (0.10)
Ashkenazi Jewish 2.24 (0.02) 1.04 (0.10) 3.44 (0.01)
P values are given in parentheses.
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signaling pathway is not present in these cells. High levels of the
AKT-1 SNPs (3 and 4) were only weakly associated with a low
apoptotic frequency (P 0.07). The remainder of the observations
and figures from these publications remain correct. Because of
these duplications in cell lines, the DNA samples were obtained
from 91 unrelated individuals, males and females, of which 38 were
self-reported Caucasians and 53 were self-reported African Amer-
icans. The allele frequencies for this group are presented in Table
1. SNP Cel-9 was monomorphic in the African American cohort
and was thus eliminated in the detailed computational analysis of
this population. Both races agreed on the major allele at each locus
except SNP Cel11.
MDM2 SNPs and genotyping. Genotyping of SNPs was performed by
allele-specific real-time PCR for individual samples using primers
designed and validated in-house (25). Previous analyses showed
that the accuracy of our genotyping is better than 99%, as deter-
mined by internal comparisons of differentially designed assays for
the same marker and comparisons for the same marker across
different groups (36).
Sheba Medical Center. Sample population. Study participants were all
of Jewish Ashkenazi origin previously counseled and tested at the
Oncogenic unit, Sheba Medical Center, Tel Hashomer, Israel,
because of a family history of breast and/or ovarian cancer. The
study was approved by the institutional review boards (Helsinki
committees) at Sheba Medical Center and the national IRB for
genetics. A control population made up of healthy Ashkenazi
women (n  139) with no family history or personal history of
cancer and no BRCA1/2 mutations were accrued through the
genetic center at the Sheba Medical Center. These women were
referred for genetic testing for nonneoplastic conditions and gave
their written informed consent for anonymous testing. To prevent
ascertainment bias of the haplotype inferences, we used only the
control group in the analyses; thus, it is assumed that the data set
in this paper, labeled as the Askenazi Jewish population, is
a random sample from the representative (non-cancer risk)
population.
DNA preparation. Genomic DNA was prepared from anticogulated,
venous blood samples by using the PUREGene DNA isolation kit
(Gentra Systems, Minneapolis, MN) using the protocol recom-
mended by the manufacturer.
MDM2 SNPs and genotyping. Six SNPs were genotyped in a region
in and adjacent to the MDM-2 SNP309 locus spanning 4,000 bp
upstream to the eighth intron (Fig. 1).
SNPs for genotyping in the MDM-2 gene were selected from
three different databases; www.ensembl.org, www.broad.mit.edu/
mpg/haploview, and dbsnp (www.ncbi.nlm.nih.gov/snp) based on
their location in theMDM-2 gene. SNP genotyping was performed
in 384-wellmicroplateswith a high-throughout systemof chip-based
mass spectrometry (MALDI-TOF) (Sequenomx, San Diego, CA).
The allele determination in the sampled DNA was based on
MALDI-TOF mass spectrometry of allele-specific primer prod-
ucts. Genotyping assays were designed as multiplex reactions using
SpectroDESIGNER software version 2.0.7 (Sequenom).
PCR Primer Design, Amplification, and Primer Extension.The detailed
PCR and primer extension reactions were performed according to
the protocol for high multiplex homogeneous MassEXTEND
(hME) procedure (Sequenom application notes), as follows. PCR
primers were tagged with 5-ACGTTGGATG-3 at the 5 end to
avoid interference with the mass spectra. Amplification of 2.5 ng of
cDNA was performed in 2.75 mM MgCl2/200 M dNTP/0.1 unit
of HotStart TaqDNA polymerase (Qiagen) and 1 pmol of each
forward and reverse PCR primers in 5-l total volume. PCR
conditions: 95°C 15min, followed by 45 cycles of 95°C for 30 s, 56°C
for 1 min, then 72°C for 1:30 min, with an extension at 72°C for 7
min. Products were then treated with 0.04 unit of shrimp alkaline
phosphatase (SAP) (Sequenom) followed by extension cycle, to
which 1.2 M final concentration of extension primer and 0.6 unit
of ThermoSequenase (Sequenom) were added to a total reaction
of 9 l with the termination mixture. The extension conditions
include a 94°C 2 min with 75 cycles of the following: 94°C for 5 s,
52°C for 5 s and 72°C for 5 s. Quality control and quality assurance
were provided by randomly including non-DNA containing well in
the chip as well as regenotyping 10% of samples for all SNPs on
different chips. The error rate of reproducibility due to missed calls
was 3.4%.
Haplotying. The predictions of haplotypes from the genotyping,
carried out with the three different populations, were calculated
employing the Bayesian algorithm known as PHASE, version 2.1
(37). Note that the limited number of samples in both the Celera
and Sheba studies preclude discovery of rare haplotypes. To test
Hardy–Weinberg equilibrium of the genotypes, stratified by pop-
ulation, an exact test based on the Markov chain algorithm of Guo
and Thompson (38) was used, as implemented by Excoffier et al.
(26). This method compares the observed heterozygosity to the
expected heterozygosity in each population under study.
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